Usage patterns of biomarkers in non-small-cell lung cancer patients in India: Findings from a systematic review and survey

Usage patterns of biomarkers in non-small-cell lung cancer patients in India: Findings from a systematic review and survey

Introduction: Personalized medicine has facilitated improved management of non-small cell lung cancer (NSCLC) patients by identifying predictive and prognostic biomarkers for enhanced efficiency of detection and efficacy of treatment. This systematic review and survey assessed the patterns of biomar...

Full description

Bibliographic Details
Main Authors:	Chirag Desai, Anurag Mehta, Divya Mishra
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2014-01-01
Series:	Lung India
Subjects:	Biomarkers India non small cell lung cancer prognosis tumor markers
Online Access:	http://www.lungindia.com/article.asp?issn=0970-2113;year=2014;volume=31;issue=3;spage=249;epage=259;aulast=Desai

Similar Items

The role of genetic and other biomarkers in NSCLC prognosis
by: Schveigert Diana, et al.
Published: (2014-06-01)

Molecular Characterisation and Prognostic Biomarker Discovery in Human Non-Small Cell Lung Cancer
by: Edlund, Karolina
Published: (2012)

Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
by: Zhang Zhihui, et al.
Published: (2021-04-01)

Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis
by: Wu Q, et al.
Published: (2019-05-01)

OSluca: An Interactive Web Server to Evaluate Prognostic Biomarkers for Lung Cancer
by: Zhongyi Yan, et al.
Published: (2020-05-01)

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer
by: Yang Hong, et al.
Published: (2021-03-01)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
by: Zhengliang Tu, et al.
Published: (2021-04-01)

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
by: Yingji Chen, et al.
Published: (2021-04-01)

Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival
by: Zhou Chun-Hui, et al.
Published: (2012-03-01)

Potential Prospective Biomarkers for Non-small Cell Lung Cancer: Mini-Chromosome Maintenance Proteins
by: Chen Huang, et al.
Published: (2021-04-01)

The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis
by: Chuchu Shao, et al.
Published: (2019-11-01)

Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer
by: Yujiao Xie, et al.
Published: (2018-05-01)

Network biomarkers, interaction networks and dynamical network biomarkers in respiratory diseases
by: Xiaodan Wu, et al.
Published: (2014-12-01)

Biomarkers in chronic obstructive pulmonary disease patients for prediction of lung cancer development
by: Murali M S Balla, et al.
Published: (2018-01-01)

Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma
by: Zhou CS, et al.
Published: (2021-02-01)

Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers
by: Milena Matuszczak, et al.
Published: (2020-05-01)

miR-1323 Promotes Cell Migration in Lung Adenocarcinoma by Targeting Cbl-b and Is an Early Prognostic Biomarker
by: Huan Zhao, et al.
Published: (2020-02-01)

Non-Coding RNAs as Prognostic Biomarkers: A miRNA Signature Specific for Aggressive Early-Stage Lung Adenocarcinomas
by: Elisa Dama, et al.
Published: (2020-12-01)

Comprehensive analysis of gene expression and DNA methylation data identifies potential biomarkers and functional epigenetic modules for lung adenocarcinoma
by: XiaoCong Wang, et al.

Sputum-Based Molecular Biomarkers for the Early Detection of Lung Cancer: Limitations and Promise
by: William N. Rom, et al.
Published: (2011-07-01)

Advances in Exosomes in the Pathogenesis and Diagnosis of Lung Cancer
by: Huanhuan BI, et al.
Published: (2020-07-01)

Identification of small proline‐rich protein 1B (SPRR1B) as a prognostically predictive biomarker for lung adenocarcinoma by integrative bioinformatic analysis
by: Zihe Zhang, et al.
Published: (2021-03-01)

The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review
by: Frederik van Delft, et al.
Published: (2020-04-01)

miR-4284 Promotes Cell Proliferation, Migration, and Invasion in Non-Small Cell Lung Cancer Cells and is Associated with Postoperative Prognosis
by: Yang H, et al.
Published: (2021-07-01)

The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer
by: Qiang Guo, et al.
Published: (2021-07-01)

Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer
by: Max Hardy-Werbin, et al.
Published: (2019-06-01)

Overexpression of hsa_circ_0001715 is a Potential Diagnostic and Prognostic Biomarker in Lung Adenocarcinoma
by: Lu G, et al.
Published: (2020-10-01)

An Evidence-Based Approach to the Use of Predictive Biomarkers in the Treatment of Non- Small Cell Lung Cancer (NSCLC)
by: Cindy Quinton, et al.
Published: (2011-09-01)

Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer
by: Jiehan Jiang, et al.
Published: (2021-04-01)

Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
by: Zhibo Zhang, et al.
Published: (2020-06-01)

Hypertension as a predictive biomarker in patients with advanced non-small-cell lung cancer treated with apatinib
by: Fang SC, et al.
Published: (2019-02-01)

High expression of MCM10 is predictive of poor outcomes in lung adenocarcinoma
by: Mingrui Shao, et al.
Published: (2021-02-01)

Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China
by: Yang YL, et al.
Published: (2018-01-01)

A multicenter pilot study examining the role of Circulating Tumor Cells (CTCs) as a blood-based tumor marker in patients with extensive small cell lung cancer (EX-SCLC)
by: Chao H Huang, et al.
Published: (2014-10-01)

PHLPP2 as a novel metastatic and prognostic biomarker in non‐small cell lung cancer patients
by: Hongmei Wang, et al.
Published: (2019-11-01)

Recommendations for clinical use of tumor markers in lung cancer
by: Stanković Sanja
Published: (2007-01-01)

Expression of tumor necrosis factor receptor 2 in human non‐small cell lung cancer and its role as a potential prognostic biomarker
by: Yan Wen Zhang, et al.
Published: (2019-03-01)

Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma
by: Jiayu Ma, et al.
Published: (2021-01-01)

A nomogram to predict outcomes of lung cancer patients after pneumonectomy based on 47 indicators
by: Bo Cheng, et al.
Published: (2020-02-01)

Macrophage Inhibitory Cytokine-1 (MIC-1) as A Biomarker for Diagnosis  and Prognosis of Stage I-II Non-small Cell Lung Cancer
by: Yuning LIU, et al.
Published: (2016-04-01)